Outcomes for lymph node-positive cutaneous melanoma over two decades.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3109242)

Published in World J Surg on July 01, 2011

Authors

Steve R Martinez1, Warren H Tseng, Shawn E Young

Author Affiliations

1: Department of Surgery, Division of Surgical Oncology Sacramento, University of California at Davis, 4501 X Street, Suite 3010, Sacramento, CA 95817, USA. steve.martinez@ucdmc.ucdavis.edu

Articles cited by this

Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08

Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med (2006) 15.64

Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56

Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol (2009) 2.50

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg (2003) 2.32

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol (1988) 2.32

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res (2004) 2.28

An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin (2004) 2.18

NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68

Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas? Br J Dermatol (2001) 1.12

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer (2009) 1.02

Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys (1994) 1.01

Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control (2009) 0.99

Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg (2004) 0.98

The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Ann Surg Oncol (2008) 0.95

Baseline staging in cutaneous malignant melanoma. Br J Dermatol (2004) 0.92

Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol (1995) 0.91

Computed tomography in the detection of abdominal metastases from malignant melanoma. Invest Radiol (1984) 0.89

Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Ann Surg Oncol (1997) 0.88

Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg (1992) 0.87

Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma -- a retrospective single centre study. Melanoma Res (2004) 0.87

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol (2004) 0.82

Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control. Ann Surg Oncol (1995) 0.78